Drug-cytokine interactions: mechanisms and clinical implications

W G Reiss1, S C Piscitelli

  • 1Department of Pharmacy Practice and Science, Pharmacokinetics-Biopharmaceutics Laboratory,School of Pharmacy, University of Maryland, Baltimore, Maryland, USA.

Insights

Cytokines can alter drug metabolism by affecting cytochrome P450 enzymes. Research is ongoing to understand the mechanisms and clinical impact of these drug-cytokine interactions.

Area of Science:

  • Pharmacology
  • Immunology
  • Drug Metabolism

Background:

  • Cytokine-induced alterations in cytochrome P450 (CYP450)-mediated drug metabolism have been recognized for over two decades.
  • In vitro studies confirm these interactions and explore potential mechanisms, though definitive understanding remains elusive.

Purpose of the Study:

  • To review the current understanding of how cytokines affect drug metabolism.
  • To highlight the proposed mechanisms and the limitations of existing clinical data.

Main Methods:

  • Review of in vitro studies investigating drug-cytokine interactions.
  • Analysis of available clinical data, including case reports and small patient studies.

Main Results:

  • Proposed mechanisms include inhibition of mRNA transcription, increased heme oxygenase and xanthine oxidase activity, and induction of cytotoxic killer cells.
  • Clinical data are limited and often conflicting, with some studies showing effects and others showing none.
  • Variability in study design (cytokine dosage, administration route, timing, patient variability) likely contributes to conflicting results.

Conclusions:

  • The precise mechanisms of drug-cytokine interactions require further elucidation.
  • Additional research is necessary to clarify the clinical significance and implications of these interactions.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Inflammatory Response01:28

Inflammatory Response

An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Pharmacokinetics: Drug–Drug Interactions01:25

Pharmacokinetics: Drug–Drug Interactions

Drug interactions occur when the pharmacological effect of one drug is altered by another substance, either enhancing or diminishing its activity. The drug whose activity is altered is known as the object drug, and the substance causing the alteration is called the agent drug or the precipitant. The net effects of these interactions are mostly undesirable, leading to decreased effectiveness or increased adverse effects. In rare cases, interactions can be beneficial, such as the enhanced...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...